Beiqing news reporter learned that readcivir is a kind of drug that has been used in the treatment of Ebola virus infection in foreign countries. At present, all clinical trials have not been completed in foreign countries. However, it has shown good in vitro activity in the process of virus screening in domestic research institutions. Previously, the State Food and drug administration has agreed that China Japan Friendship Hospital and the Chinese Academy of medical sciences can carry out clinical trials in patients infected with the new coronavirus.
According to the plan, 308 patients with mild and moderate diseases and 453 patients with severe diseases will be enrolled in the trial. Cao Bin, a professor at China Japan Friendship Hospital, said the study will carry out a strict randomized double-blind trial to evaluate the efficacy and safety of ridcivir in patients with new coronavirus pneumonia.
There is an established path for drugs from basic research to clinical practice, and all the processes should fully conform to the national drug approval process.